Zirger Jeffrey M, Barcia Carlos, Liu Chunyan, Puntel Mariana, Mitchell Ngan, Campbell Iain, Castro Maria, Lowenstein Pedro R
Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, USA.
J Virol. 2006 Jun;80(11):5655-9. doi: 10.1128/JVI.00166-06.
The innate immune response, characterized by the rapid induction of proinflammatory genes, plays an important role in immune responses to viral vectors utilized in gene therapy. We demonstrate that several innate proinflammatory mRNAs, i.e., those coding for the interferon (IFN)-regulated proteins interferon regulatory factor 1, 2',5'-oligoadenylate synthetase, and double-stranded-RNA-dependent protein kinase as well as those coding for the chemokines RANTES, IFN-gamma-inducible protein 10, and monocyte chemoattractant protein 1, were all increased in a statistically significant manner in response to 1 x 10(8) IU, but not lower doses, of a first-generation adenovirus injected into the naïve brain. This indicates the presence of a threshold dosage of adenovirus needed to elicit an acute innate inflammatory response.
以促炎基因的快速诱导为特征的先天免疫反应在对基因治疗中使用的病毒载体的免疫反应中起重要作用。我们证明,几种先天促炎mRNA,即编码干扰素(IFN)调节蛋白干扰素调节因子1、2',5'-寡腺苷酸合成酶和双链RNA依赖性蛋白激酶的mRNA,以及编码趋化因子RANTES、IFN-γ诱导蛋白10和单核细胞趋化蛋白1的mRNA,在向未接触过病毒的脑内注射1×10⁸国际单位(IU)而非更低剂量的第一代腺病毒后,均有统计学意义的增加。这表明引发急性先天炎症反应所需的腺病毒存在阈值剂量。